Heart failure and left ventricular dysfunction in older patients with chronic kidney disease: the China Hypertension

Xin Wang1, Guang Hao2, Lu Chen1

  • 1Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

Heart failure (HF) and left ventricular (LV) dysfunction are common in older adults with chronic kidney disease (CKD). Smoking is a significant risk factor for HF and LV diastolic dysfunction in this population.

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics

Background:

  • Heart failure (HF) is a major cause of hospitalization and mortality in elderly patients with chronic kidney disease (CKD).
  • Epidemiological data on HF and left ventricular (LV) dysfunction in this demographic is limited.
  • Understanding the prevalence and risk factors is crucial for targeted interventions.

Purpose of the Study:

  • To determine the prevalence of LV dysfunction and HF in older adults with CKD.
  • To identify risk factors associated with HF in this patient group.

Main Methods:

  • Cross-sectional analysis of the China Hypertension Survey (2012-2015).
  • Inclusion of 5,808 participants aged ≥ 65 years.
  • Assessment of HF history, cardiovascular diseases, and LV dysfunction via echocardiography.
  • Definition of CKD based on eGFR and urinary albumin-to-creatinine ratio (ACR).

Main Results:

  • The weighted prevalence of HF was 4.8% among elderly CKD patients.
  • Prevalence of HF was 5.0% with eGFR < 60 mL/min/1.73 m² and 5.9% with ACR ≥ 30 mg/g.
  • LV systolic dysfunction prevalence was 3.1%, and moderate/severe diastolic dysfunction was 8.9%.
  • Smoking was significantly associated with HF risk.
  • Age, smoking, and rural residence were linked to LV diastolic dysfunction risk.

Conclusions:

  • A high prevalence of HF and LV dysfunction exists in older CKD patients.
  • Targeted strategies are necessary to manage HF and LV dysfunction in this vulnerable population.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
171
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
206
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
373
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
378
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
152